Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Katz Karp

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Archives of Pathology & Laboratory Medicine|November 29, 2013
Lymphangioma of the palatine tonsilStacey Mardekian, Julie Katz Karp
Archives of Pathology & Laboratory Medicine|October 31, 2018
Transfusion-Transmitted BabesiosisTatiana Villatoro, Julie Katz Karp
Transfusion|February 13, 2021
How do I…perform therapeutic phlebotomy?Alexis R Peedin, Julie Katz Karp
Journal of Clinical Apheresis|August 6, 2021
Therapeutic plasma exchange in patients with severe obesity (BMI >40): A survey of practices in the United StatesShraddha Patel Babariya, Angelica Vivero, Alexis Peedin, et al.
Journal of Clinical Apheresis|January 27, 2023
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplantAngelica Vivero, Alexis R Peedin, Yuanzheng Gao, et al.
Journal of Clinical Apheresis|December 16, 2024
What's in a Name: Your PLEX or PEX Is Our TPEZiver Sahin, Aaron Christensen, Juliana Guarente, et al.
Transfusion|April 13, 2026
Routine transfusion of Rh(D)-positive RBCs to Rh(D)-negative patients designated as do not resuscitate conserves Rh(D)-negative red blood cell inventoryJulie Katz Karp, Jovanna Everetts, Juliana Guarente, et al.
Applied Health Economics and Health Policy|July 10, 2016
Cost of Purchased Versus Produced Plasma from Donor Recruitment Through TransfusionKatherine M Prioli, Laura T Pizzi, Julie Katz Karp, et al.
JCO Oncology Practice|February 22, 2022
Optimizing Utilization of Blood Products in the Hematologic Malignancy Clinic: Less Is MoreAdam F Binder, Katy Loos, Alexander Xu, et al.
Applied Health Economics and Health Policy|August 1, 2018
Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact ModelKatherine M Prioli, Julie Katz Karp, Nina M Lyons, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Archives of Pathology & Laboratory Medicine|November 29, 2013
Lymphangioma of the palatine tonsilStacey Mardekian, Julie Katz Karp
Archives of Pathology & Laboratory Medicine|October 31, 2018
Transfusion-Transmitted BabesiosisTatiana Villatoro, Julie Katz Karp
Transfusion|February 13, 2021
How do I…perform therapeutic phlebotomy?Alexis R Peedin, Julie Katz Karp
Journal of Clinical Apheresis|August 6, 2021
Therapeutic plasma exchange in patients with severe obesity (BMI >40): A survey of practices in the United StatesShraddha Patel Babariya, Angelica Vivero, Alexis Peedin, et al.
Journal of Clinical Apheresis|January 27, 2023
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplantAngelica Vivero, Alexis R Peedin, Yuanzheng Gao, et al.
Journal of Clinical Apheresis|December 16, 2024
What's in a Name: Your PLEX or PEX Is Our TPEZiver Sahin, Aaron Christensen, Juliana Guarente, et al.
Transfusion|April 13, 2026
Routine transfusion of Rh(D)-positive RBCs to Rh(D)-negative patients designated as do not resuscitate conserves Rh(D)-negative red blood cell inventoryJulie Katz Karp, Jovanna Everetts, Juliana Guarente, et al.
Applied Health Economics and Health Policy|July 10, 2016
Cost of Purchased Versus Produced Plasma from Donor Recruitment Through TransfusionKatherine M Prioli, Laura T Pizzi, Julie Katz Karp, et al.
JCO Oncology Practice|February 22, 2022
Optimizing Utilization of Blood Products in the Hematologic Malignancy Clinic: Less Is MoreAdam F Binder, Katy Loos, Alexander Xu, et al.
Applied Health Economics and Health Policy|August 1, 2018
Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact ModelKatherine M Prioli, Julie Katz Karp, Nina M Lyons, et al.
Pageof 2